The expression of Cdt1 is frequently elevated in aggressive human hepatocellular carcinomas and in various breast and gastric carcinomas, suggesting aberrantly elevated levels of Cdt1 may contribute to these malignancies [40,49,50]. This evidence concerns the gene CDT1 and gastric carcinoma.